English court invalidates HGS’s gene-sequencing patent
This article was originally published in Scrip
An English judge has declared invalid a Human Genome Sciences (HGS) patent disclosing the nucleotide and amino acid sequence of a novel member of the TNF ligand superfamily known as Neutrokine-alpha. Among the arguments Mr Justice Kitchin accepted from Lillywas that the invention was not capable of industrial application as required under patent legislation. He also found that the patent was invalid for insufficiency and obviousness.
You may also be interested in...
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.